[1] 黄小瑾, 张招娣, 李佳霖, 等. 中医药内外兼治对125例湿热蕴脾口腔扁平苔藓患者临床疗效观察[J]. 中华中医药杂志, 2019, 34(2): 411-414. [2] Müller S.Oral lichenoid lesions: distinguishing the benign from the deadly[J]. Modern Pathol, 2017, 30(s1): S54-67. [3] 于世凤. 口腔组织病理学[M]. 第7版. 北京: 人民卫生出版社, 2012: 234-235. [4] 姚辉, 李慧源, 周永梅, 等. 口腔扁平苔藓T细胞受体BV基因的优势取用初探[J]. 上海口腔医学, 2011, 20(1): 76-79. [5] Lucchesi D, Pitzalis C, Bombardieri M.EBV and other viruses as triggers of tertiary lymphoid structures in primary Sjögren's syndrome[J]. Expert Rev Clin Immunol, 2014, 10(4): 445-455. [6] van de Pavert, Mebius RE, et al. New insights into the development of lymphoid tissues[J]. Nat Rev Immunol, 2010, 10(9): 664-674. [7] Neyt K, Perros F, van Geurts Kessel CH, et al. Tertiary lymphoid organs in infection and autoimmunity[J]. Trends Immunol, 2012, 33(6): 297-305. [8] Cupedo T, Jansen W, Kraal G, et al.Induction of secondary and tertiary lymphoid structures in the skin[J]. Immunity, 2004, 21(5): 655-667. [9] Astorri E, Scrivo R, Bombardieri M, et al.CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjögren's syndrome[J]. Rheumatology(Oxford), 2014, 53(4): 611-620. [10] Theander E, Vasaitis L, Baecklund E, et al.Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome[J]. Ann Rheum Dis, 2011, 70(8): 1363-1368. [11] Pitzalis C, Jones GW, Bombardieri M, et al.Ectopic lymphoid-like structures in infection, cancer and autoimmunity[J]. Nat Rev Immunol, 2014, 14(7): 447-462. [12] 王燕娟, 沈玉娟, 徐馀信, 等. 免疫组化法观察日本血吸虫感染破坏小鼠脾脏淋巴滤泡结构[J]. 中国血吸虫病防治杂志, 2017, 29(4): 468-470. [13] Wang Y, Shang S, Sun Q, et al.Increased infiltration of CD11c+/CD123+ dendritic cell subsets and upregulation of TLR/IFN-alpha signaling participate in pathogenesis of oral lichen planus[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 125(5): 459-467. [14] Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al.Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers[J]. J Clin Oncol, 2013, 31(36): 4550-4559. |